150 related articles for article (PubMed ID: 1866556)
1. Empiric therapy with amphotericin B in febrile granulocytopenic patients.
Walsh TJ; Lee J; Lecciones J; Rubin M; Butler K; Francis P; Weinberger M; Roilides E; Marshall D; Gress J
Rev Infect Dis; 1991; 13(3):496-503. PubMed ID: 1866556
[TBL] [Abstract][Full Text] [Related]
2. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
5. Empiric antifungal therapy in the management of the febrile-granulocytopenic cancer patient.
Commers JR; Pizzo PA
Pediatr Infect Dis; 1983; 2(1):56-60. PubMed ID: 6835857
[No Abstract] [Full Text] [Related]
6. Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia.
Karp JE; Merz WG; Charache P
Rev Infect Dis; 1991; 13(4):592-9. PubMed ID: 1925275
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
9. Empiric amphotericin B therapy: the need for a reappraisal.
Fraser IS; Denning DW
Blood Rev; 1993 Dec; 7(4):208-14. PubMed ID: 8130683
[TBL] [Abstract][Full Text] [Related]
10. Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Bow EJ; Louie TJ
CMAJ; 1987 Sep; 137(5):397-403. PubMed ID: 3304600
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
Malik IA; Moid I; Aziz Z; Khan S; Suleman M
Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
[TBL] [Abstract][Full Text] [Related]
12. Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
Joshi JH; Schimpff SC; Tenney JH; Newman KA; de Jongh CA
Am J Med; 1984 Mar; 76(3):450-7. PubMed ID: 6702875
[TBL] [Abstract][Full Text] [Related]
13. Reduction of systemic fungal infections in patients with hematological malignancies, neutropenia, and prolonged fever by early amphotericin B therapy.
Zimmermann-Hösli MB; Stahel RA; Vogt P; Oelz O
Klin Wochenschr; 1988 Oct; 66(20):1010-4. PubMed ID: 3236752
[TBL] [Abstract][Full Text] [Related]
14. Empiric amphotericin B therapy in patients with acute leukemia.
Holleran WM; Wilbur JR; DeGregorio MW
Rev Infect Dis; 1985; 7(5):619-24. PubMed ID: 3903941
[TBL] [Abstract][Full Text] [Related]
15. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].
Tong HY; Zhang FJ; Xiao F; Qian WB; Meng HT; Mai WY; Tong Y; Mao LP; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181
[TBL] [Abstract][Full Text] [Related]
19. [Decrease in systemic fungal infections in hematological neoplasms with empirical use of amphotericin B therapy].
Zimmermann-Hölsi MB; Stahel RA; Vogt P; Oelz O
Schweiz Med Wochenschr; 1989 Jan; 119(2):46-8. PubMed ID: 2916109
[TBL] [Abstract][Full Text] [Related]
20. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
Sobel JD
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
